Niva Bupa Health Insurance Company Limited has informed the Exchange regarding Appointment of Mr. Vishwanath Mahendra as Whole-time Director of the company w.e.f. May 07, 2025.
NIVABUPA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Niva Bupa's board approved several key changes on May 7, 2025. Two internal executives — current CFO Vishwanath Mahendra and Chief Distribution Officer Ankur Kharbanda — were elevated to Whole-time Director roles for five-year terms each. Chief Risk Officer Joanne Elizabeth Woods resigned (effective May 7, 2025), and Vipul Sharma was appointed as the new EVP & Chief Risk Officer from May 8, 2025. The board also approved the grant of 63,12,187 Employee Stock Options under the ESOP Scheme 2024 to eligible employees. Additionally, Nangia & Co. LLP was appointed as Statutory Auditor for four years (till 2029 AGM), and Ranjeet Pandey & Associates as Secretarial Auditor for five years. All appointments are subject to shareholder and IRDAI approval where applicable.
Continuity in leadership is maintained as both Whole-time Director appointees are existing senior executives with deep familiarity in the health insurance business. The CRO change is a routine succession with no governance flags raised. The ESOP grant may cause mild future dilution but aligns employee interests with shareholders. Overall, this is a routine governance update with neutral to mildly positive sentiment.